(Q44820307)

English

CD21+ (B2 antigen+) cell decrement and CD4+ CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis

scientific article published on August 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

CD21+ (B2 antigen+) cell decrement and CD4+ CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis (English)

reason for preferred rank

most precise value

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

CD21+ (B2 antigen+) cell decrement and CD4+CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712366

5 November 2022

multiple sclerosis

0 references

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

author name string

D. Gambi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712366

5 November 2022

A. M. Porrini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712366

5 November 2022

A. Giampietro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712366

5 November 2022

S. Macor

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712366

5 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712366

5 November 2022

publication date

1 August 1991

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:016557289190053A?httpAccept=text/xml

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

https://api.elsevier.com/content/article/PII:016557289190053A?httpAccept=text/plain

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

97-102

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Activated suppressor cell function in multiple sclerosis--clinical correlations

1

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.

2

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

A rapid, no-wash technic for immunophenotypic analysis by flow cytometry

4

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Absence of a correlation between T lymphocyte subsets and clinical activity in relapsing-remitting multiple sclerosis

5

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis

6

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Neurologic impairment in multiple sclerosis and the disability status scale.

8

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Multiple sclerosis (first of two parts).

9

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Multiple sclerosis (second of two parts).

10

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

11

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

12

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

13

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

The isolation and characterization of the human helper inducer T cell subset

14

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

The isolation and characterization of the human suppressor inducer T cell subset

15

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

The cellular basis for the induction of antigen-specific T8 suppressor cells

17

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man

18

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Cell-mediated immune functions in multiple sclerosis

20

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases

22

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis

23

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

24

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes

25

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system

26

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Multiple sclerosis: heterology among early T cells and Tg cells

27

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

28

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

29

1 reference

10.1016/0165-5728(91)90053-A

https://api.crossref.org/works/10.1016/0165-5728(91)90053-A

5 November 2022

Identifiers

10.1016/0165-5728(91)90053-A

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44820307&oldid=1765371114"